Cargando…
Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy
Dipeptidyl peptidase 4 inhibitors and angiotensin II receptor blockers attenuate chronic kidney disease progression in experimental diabetic and non-diabetic nephropathy in a blood pressure and glucose independent manner, but the exact molecular mechanisms remain unclear. MicroRNAs (miRNAs) are shor...
Autores principales: | Delić, Denis, Wiech, Franziska, Urquhart, Richard, Gabrielyan, Ogsen, Rieber, Kathrin, Rolser, Marcel, Tsuprykov, Oleg, Hasan, Ahmed A., Krämer, Bernhard K., Baum, Patrick, Köhler, Andreas, Gantner, Florian, Mark, Michael, Hocher, Berthold, Klein, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042229/ https://www.ncbi.nlm.nih.gov/pubmed/32099009 http://dx.doi.org/10.1038/s41598-020-60336-4 |
Ejemplares similares
-
Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl(4) Treated Rats
por: Broermann, Andre, et al.
Publicado: (2020) -
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients
por: Delić, Denis, et al.
Publicado: (2016) -
Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK)
por: Grempler, Rolf, et al.
Publicado: (2018) -
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013) -
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans
por: Tammen, Harald, et al.
Publicado: (2023)